Table 2. Evaluation of the three groups after 3 months.
| ADT group (n=46) | Non-ADT group (n=37) | Control group (n=50) | P value* | ||||
|---|---|---|---|---|---|---|---|
| 3 months | Change | 3 months | Change | 3 months | Change | ||
| Testosterone (ng dl−1) | 39±19 | −410±151 | 386±131 | −23±72 | 458±156 | 33±71 | <0.001 |
| Waist circumference (cm) | 87.2±6.9 | 0.6±3.1 | 85.4±5.5 | −0.2±2.5 | 86.3±6.2 | 0.3±2.7 | 0.373 |
| Fasting insulin (mU l−1) | 22.47±5.64 | 7.26±2.50 | 16.89±4.06 | 0.64±2.96 | 15.68±3.22 | 1.23±2.63 | <0.001 |
| Fasting glucose (mmol l−1) | 5.39±0.69 | 0.16±0.47 | 5.58±0.47 | 0.23±0.34 | 5.34±0.54 | 0.14±0.56 | 0.689 |
| Total cholesterol (mmol l−1) | 5.14±0.67 | 0.32±0.47 | 4.95±0.67 | 0.15±0.36 | 4.82±0.51 | 0.17±0.31 | 0.070 |
| Triglyceride (mmol l−1) | 1.60±0.42 | 0.05±0.32 | 1.55±0.41 | 0.08±0.37 | 1.43±0.31 | 0.03±0.23 | 0.762 |
| HDL (mmol l−1) | 1.41±0.31 | 0.09±0.24 | 1.29±0.22 | 0.01±0.27 | 1.35±0.25 | 0.10±0.21 | 0.192 |
| LDL (mmol l−1) | 3.21±0.48 | 0.18±0.45 | 3.02±0.65 | 0.15±0.69 | 2.97±0.55 | −0.11±0.45 | 0.012 |
Abbreviations: ADT, androgen deprivation therapy; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
*One-way analysis of variance was used to compare “change from baseline” among the three groups.